Cheniere Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017

◆英語タイトル:Cheniere Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis - 2017
◆商品コード:DATA904C3231
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:グローバル
◆産業分野:石油・ガス
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Cheniere Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
Summary

Cheniere Energy Inc (Cheniere) is a midstream energy company that owns and operates LNG-related businesses. The company through its general partner, Cheniere Energy Partners, L.P. (Cheniere Partners) and Cheniere Energy Partners LP Holdings (Cheniere Holdings) owns and operates the Sabine Pass LNG receiving terminal and Creole Trail Pipeline. The company’s LNG terminal projects under construction are the Sabine Pass LNG terminal and the Corpus Christi LNG terminal. Cheniere is also engaged in the LNG and natural gas marketing business through its subsidiaries. It has offices London, Tokyo, Washington, Singapore, Santiago and Beijing. Cheniere is headquartered in Houston, Texas, the US.

Cheniere Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key operational metrics, analysis and provides a strategic insight into the company. The report provides an annual and quarterly overview of oil and gas reserves and production, changes in reserves, costs incurred and results of oil and gas operations, acreage and well details, share price performance and key valuation metrics.

Scope

The report provides in-depth analysis and insights into companies’ capital spending, revenues, oil and gas reserves, production, and performance measures. Its scope includes the following –
- The report provides detailed and unique insight information on the key operational metrics. It gives a comprehensive overview of oil and gas production and reserves, costs incurred and results of oil and gas operations, acreage and well details and other performance metrics.
- Provides details with respect to the company’s oil and gas reserves and production information by country. It further consists of in-depth information on the company’s expenditures in relation to the acquisition, exploration and development activities; developed and undeveloped acreage position; key costs and revenue information; and performance metrics of the company as disclosed in its annual reports and regulatory filings.
- Provides a comprehensive overview of the company’s share price performance and key valuation metrics such as market capitalization, enterprise value, EV/Production ($boe/d) and EV/Proved Reserve ($/boe)
- Provides information on key operational and financial metrics on an annual and quarterly basis. The annual information provided is for a five-year period and the quarterly information is for the last five quarters.

*Note:

1. The scope mentioned above is generic and may not apply to all the companies. The report is based on the information disclosed by the companies in their annual and quarterly reports, regulatory filings and other company documents and sources.
2. Quarterly information is provided only for the companies that are December ending and files quarter reports and documents.
3. There can be cases where countries/regions data column/Charts will be blank. This can be due to the fact that the company might have discontinued the reporting of those countries/regions. Information that is not disclosed by the company may not be available in the report.

Reasons to buy

The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to –
- Be up-to-date with the latest information and in-depth analysis of the operational metrics of the company.
- Identify M&A targets from up-to-date information and in-depth analysis on financial and operational metrics of your competitors.
- Rank your performance against other companies in the exploration and production (E&P) sector using operational and financial benchmarking metrics.
- Formulate your strategies based on in-depth analysis of your competitors’ financial and operational data.
- Exploit the strengths and weakness of your closest competitors by comparing and analyzing their financial and operational metrics.
- Establish relative performance among the industry’s players based on key operational and financial measures.

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 3
Company Snapshot 4
Key Information 4
Company Overview 4
Cheniere Energy Inc, Valuation and Financial Data, 2013-2017 5
Cheniere Energy Inc, Share Price Performance, 2013-2017 5
Share Price Performance, 2013-2017 5
Key Valuation Metrics, 2013-2017 7
Recent Developments 8
Cheniere Energy Inc – Recent Developments 8
Aug 09, 2018: Cheniere reports Q2 2018 results 8
Aug 09, 2018: Cheniere reports Q2 2018 results 10
Aug 09, 2018: Cheniere reports Q2 2018 results 13
Jul 30, 2018: LNG Tanker Registers 4,000th Neopanamax Transit Through Panama Canal 16
Jul 10, 2018: CME Group and Cheniere to jointly develop LNG futures contract 17
Jul 02, 2018: CPC, Taiwan (CPC) And US-Based Cheniere Energy Signed Heads Of Agreement (HOA) For 25-Year LNG Sales And Purchase Cooperation 18
Jun 19, 2018: GasLog Partners Announces New Charter Agreement With Cheniere Energy 18
Jun 15, 2018: Bechtel To Proceed With Construction Of Chenieres LNG Program Expansion 18
May 22, 2018: Cheniere Makes Positive Final Investment Decision On Train 3 At Corpus Christi Liquefaction Project 19
May 04, 2018: Cheniere Reports Record First Quarter 2018 Results And Raises Full Year 2018 Guidance 20
Appendix 23
Methodology 23
Coverage 23
Secondary Research 23
Primary Research 24
Data Information Sources 24
Company Source 24
SEC/Other Regulatory Filings 24
Other Sources 24
Expert Panel Validation 24
Data Definition 24
Oil and Gas Reserves 24
Units of Measure 25
About GlobalData 26
Disclosure 26
Disclaimer 26

List of Tables
Table 1: Cheniere Energy Inc, Key Facts 4
Table 2: Cheniere Energy Inc, Share Price Performance, 2013-2017 6
Table 3: Cheniere Energy Inc, Key Valuation Metrics, 2013-2017 7

List of Figures
Figure 1: Cheniere Energy Inc, Share Price Performance, USD/Share, 2013-2017 5

★海外企業調査レポート[Cheniere Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis – 2017]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • F-Secure Oyj (FSC1V):企業の財務・戦略的SWOT分析
    F-Secure Oyj (FSC1V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Ferrovial, S.A. (FER):企業の財務・戦略的SWOT分析
    Ferrovial, S.A. (FER) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Anacor Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Anacor Pharmaceuticals Inc (Anacor) is a biopharmaceutical company that discovers, develops and markets small molecule therapeutics based on its boron chemistry platform. The company’s marketed products include a topical solution which is an oxaborole antifungal that is used for the topical …
  • Crown Bioscience Inc (6554):医療機器:M&Aディール及び事業提携情報
    Summary Crown Bioscience Inc (Crown Bioscience) is a drug discovery company that provides drug discovery and development services. The company offers antibodies, proteins, cell lines, tumor samples, in vivo and in vitro research reagents. It offers services such as preclinical research services, onc …
  • KitCheck Inc:医療機器:M&Aディール及び事業提携情報
    Summary KitCheck Inc (KitCheck) is a provider of automated hospital pharmacy kit processing and medication tracking software solution. The company’s Kit Check is an automated medication tray management system based on scalable cloud software platform uses RFID tags to track each medication that help …
  • Noven Pharmaceuticals, Inc.:企業の戦略・SWOT・財務情報
    Noven Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Noven Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Proactis Holdings Plc (PHD):企業の財務・戦略的SWOT分析
    Summary Proactis Holdings PLC (Proactis) is a technology company. The company develops and provides spend control and eprocurement solutions. It offers various solutions such as purchase-to-pay, eCommerce, source-to-contract, and global framework. It provides source-to-contract solutions for supplie …
  • Apple Inc:戦略・SWOT・企業財務分析
    Apple Inc - Strategy, SWOT and Corporate Finance Report Summary Apple Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • K&H Bank Zrt:企業の戦略・SWOT・財務情報
    K&H Bank Zrt - Strategy, SWOT and Corporate Finance Report Summary K&H Bank Zrt - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Temasek Holdings (Private) Ltd:企業の戦略・SWOT・財務分析
    Temasek Holdings (Private) Ltd - Strategy, SWOT and Corporate Finance Report Summary Temasek Holdings (Private) Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Cabela’S Inc
    Cabela'S Inc - Strategy, SWOT and Corporate Finance Report Summary Cabela'S Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Five Prime Therapeutics Inc (FPRX):企業の財務・戦略的SWOT分析
    Five Prime Therapeutics Inc (FPRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Visa Inc:企業の戦略・SWOT・財務分析
    Visa Inc - Strategy, SWOT and Corporate Finance Report Summary Visa Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • PICC Property and Casualty Co Ltd:企業の戦略・SWOT・財務情報
    PICC Property and Casualty Co Ltd - Strategy, SWOT and Corporate Finance Report Summary PICC Property and Casualty Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • JGC Holdings Corp (1963):企業の財務・戦略的SWOT分析
    JGC Holdings Corp (1963) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Generex Biotechnology Corp (GNBT):医療機器:M&Aディール及び事業提携情報
    Summary Generex Biotechnology Corp (Generex) carries out the research, development and commercialization of drug delivery systems and technologies. It developed a proprietary platform technology to deliver drugs into the human body through the oral cavity. The company’s proprietary liquid formulatio …
  • Guangzhou R&F Properties Co Ltd:企業の戦略・SWOT・財務情報
    Guangzhou R&F Properties Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Guangzhou R&F Properties Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • KDDI Corporation:企業の戦略・SWOT・財務分析
    KDDI Corporation - Strategy, SWOT and Corporate Finance Report Summary KDDI Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Showa Shell Sekiyu KK (5002):企業の財務・戦略的SWOT分析
    Showa Shell Sekiyu KK (5002) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Immune Pharmaceuticals Inc (IMNP):企業の財務・戦略的SWOT分析
    Summary Immune Pharmaceuticals Inc (Immune Pharma) formerly EpiCept Corp is a drug development company that develops novel therapies for immunologic and inflammatory diseases. The company’s pipeline products include Bertilimumab and Nanocyclo. Its Bertilimumab is a human monoclonal antibody designed …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆